Published June 30, 2026 · Category: News

Overview

Polyendocrine metabolic ovarian syndrome is underdiagnosed and inconsistenly managed, according to Nice

Up to 4 million women with irregular periods should be investigated for polyendocrine metabolic ovarian syndrome, according to new NHS guidance.

Details

PMOS, previously known as polycystic ovarian syndrome, is believed to affect up to 13% of reproductive age women, the World Health Organization estimates.

Continue reading...

Source

Originally published at www.theguardian.com.

Related Articles